Matches in Nanopublications for { ?s ?p "[Most patients with LIS1 mutations demonstrated posterior agyria (grade 3a, 55.3%) with thin corpus callosum (50%) and prominent perivascular spaces (67.4%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP853621.RASn-bEqsYvL8HoehEviGhYDeNCTMvo3xt-VMsPGdWe78130_assertion description "[Most patients with LIS1 mutations demonstrated posterior agyria (grade 3a, 55.3%) with thin corpus callosum (50%) and prominent perivascular spaces (67.4%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP853621.RASn-bEqsYvL8HoehEviGhYDeNCTMvo3xt-VMsPGdWe78130_provenance.
- NP606208.RAwuT0TrSeZgBCeE_Y_hv6je5A3XY5do7xOsv7gpMAuDo130_assertion description "[Most patients with LIS1 mutations demonstrated posterior agyria (grade 3a, 55.3%) with thin corpus callosum (50%) and prominent perivascular spaces (67.4%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606208.RAwuT0TrSeZgBCeE_Y_hv6je5A3XY5do7xOsv7gpMAuDo130_provenance.
- NP756480.RAbUVPg1W-vaZaBAdgz2wGCViLdkGea84E_PSkB_uJmLk130_assertion description "[Most patients with LIS1 mutations demonstrated posterior agyria (grade 3a, 55.3%) with thin corpus callosum (50%) and prominent perivascular spaces (67.4%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756480.RAbUVPg1W-vaZaBAdgz2wGCViLdkGea84E_PSkB_uJmLk130_provenance.
- assertion description "[Most patients with LIS1 mutations demonstrated posterior agyria (grade 3a, 55.3%) with thin corpus callosum (50%) and prominent perivascular spaces (67.4%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Most patients with LIS1 mutations demonstrated posterior agyria (grade 3a, 55.3%) with thin corpus callosum (50%) and prominent perivascular spaces (67.4%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.